These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 313125)
41. [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases]. Königstedt B; Zipprich R; Nilius R Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):113-21. PubMed ID: 3487441 [TBL] [Abstract][Full Text] [Related]
42. Loss of suppressor T cell function and circulating immune complexes in alcoholic cirrhosis. Echevarría S; San Miguel G; Rodríguez de Lope C; Castillo E; Pons Romero F Allergol Immunopathol (Madr); 1985; 13(5):405-10. PubMed ID: 2934964 [TBL] [Abstract][Full Text] [Related]
43. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478 [TBL] [Abstract][Full Text] [Related]
44. Serum ubiquitin-protein conjugates in normal subjects and patients with alcoholic liver diseases: immunoaffinity isolation and electrophoretic mobility. Takagi M; Yamauchi M; Takada K; Ohkawa K Alcohol Clin Exp Res; 2002 Nov; 26(11):1692-6. PubMed ID: 12436058 [TBL] [Abstract][Full Text] [Related]
45. Plasma biomarkers to diagnose alcoholic hepatitis: Are we there yet? Philips CA; Augustine P Hepatology; 2018 Jan; 67(1):449. PubMed ID: 28941362 [No Abstract] [Full Text] [Related]
46. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Cochrane AM; Moussouros A; Portmann B; McFarlane IG; Thomson AD; Eddleston ; Williams R Gastroenterology; 1977 May; 72(5 Pt 1):918-23. PubMed ID: 300342 [TBL] [Abstract][Full Text] [Related]
47. Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275. Mendenhall CL; Roos F; Moritz TE; Roselle GA; Chedid A; Grossman CJ; Rouster SD; Bennett GL; Lake JR Alcohol Clin Exp Res; 1996 Dec; 20(9):1625-30. PubMed ID: 8986214 [TBL] [Abstract][Full Text] [Related]
48. Imparied lymphocyte proliferative response to mitogen in alcoholic patients. Absence of a relation to liver disease activity. Mutchnick MG; Lee HH Alcohol Clin Exp Res; 1988 Feb; 12(1):155-8. PubMed ID: 3279848 [TBL] [Abstract][Full Text] [Related]
49. Resistance of erythrocytes to lipid peroxidation in alcoholic patients. Punchard NA; Senturk H; Teare JP; Thompson RP Gut; 1994 Dec; 35(12):1753-6. PubMed ID: 7829014 [TBL] [Abstract][Full Text] [Related]
50. Total fasting serum bile acids and beta-hexosaminidase in alcoholic liver disease. Joelsson B; Hultberg B; Isaksson A; Alwmark A; Gullstrand P; Bengmark S Clin Chim Acta; 1984 Jan; 136(2-3):203-9. PubMed ID: 6229367 [TBL] [Abstract][Full Text] [Related]
51. [Acetaldehyde-induced leukocyte migration inhibition in alcoholic liver diseases]. Nilius R; Königstedt B; Zipprich B; Busse HJ; Lorenz G Z Gesamte Inn Med; 1982 Jun; 37(12):393-7. PubMed ID: 7124038 [TBL] [Abstract][Full Text] [Related]
52. The effect of antilymphocyte globulin (ALG) on human lymphocytes in vitro: inhibition of lymphotoxin production as a sensitive indicator for ALG activity. Eife GW; Eife RF; Brendel W Cell Immunol; 1979 Aug; 46(1):35-47. PubMed ID: 314848 [No Abstract] [Full Text] [Related]
53. In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Hiserodt JC; Prieur AM; Granger GA Cell Immunol; 1976 Jun; 24(2):277-88. PubMed ID: 1084788 [No Abstract] [Full Text] [Related]
54. Transferrin metabolism in alcoholic liver disease. Potter BJ; Chapman RW; Nunes RM; Sorrentino D; Sherlock S Hepatology; 1985; 5(5):714-21. PubMed ID: 4029886 [TBL] [Abstract][Full Text] [Related]
55. Alterations of ATP levels and of energy parameters in the blood of alcoholic and nonalcoholic patients with liver damage. Hernández-Muñoz R; Glender W; Díaz-Muñoz M; Suárez J; Lozano J; Chagoya de Sánchez V Alcohol Clin Exp Res; 1991 Jun; 15(3):500-3. PubMed ID: 1877735 [TBL] [Abstract][Full Text] [Related]
56. Role of soluble cytotoxic factor in concanavalin A-induced cellular cytotoxicity to rabbit erythrocytes. Nose M; Kyogoku M Exp Cell Biol; 1979; 47(5):321-31. PubMed ID: 316782 [TBL] [Abstract][Full Text] [Related]
57. Hepatic homing of labelled lymphocytes in man. Chanard J; Bach JF; Assailly J; Funck-Brentano JL Br Med J; 1972 May; 2(5812):502-4. PubMed ID: 5064042 [TBL] [Abstract][Full Text] [Related]
58. Lymphocyte cytotoxicity to autologous hepatocytes in alcoholic liver disease. Actis G; Mieli-Vergani G; Portmann B; Eddleston AL; Davis M; Williams R Liver; 1983 Feb; 3(1):8-12. PubMed ID: 6602264 [TBL] [Abstract][Full Text] [Related]
59. Lymphocyte cytotoxicity in human liver disease using rat hepatocyte monolayer cultures. Mutchnick MG; Missirian A; Johnson AG Clin Immunol Immunopathol; 1980 Aug; 16(4):423-37. PubMed ID: 7408232 [No Abstract] [Full Text] [Related]
60. In vitro effect of prednisolone on peripheral blood suppressor T cell activity in patients with alcoholic hepatitis. Ikeda T; Daiguji Y; Hasumura Y; Takeuchi J Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):225-32. PubMed ID: 2529069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]